[Osaka City] Tackling Drug Discovery Technology Transfer with 'Volunteer WGs'. Spera Pharma Obtains 'White Company Certification' Supporting Professional Autonomy

Spera Pharma, a company specializing in CMC research, development, and contract manufacturing for pharmaceuticals, obtained 'White Company Certification' on May 1, 2026. This certification, operated by the Japan Next Generation Enterprise Promotion Organization, evaluates companies based on 70 strict criteria, including business models, flexible work practices, and human resource development. Spera Pharma was highly evaluated for its organizational flexibility, where process chemistry, formulation, and analysis departments collaborate, and for its respect for employee expertise. In particular, the company supports the autonomy of highly specialized professionals through initiatives like 'volunteer working groups' for technology transfer and the introduction of flexible work systems like coreless flex time. Based on the belief that creating excellent medicine requires an organization that embodies hope and trust, the company will continue to promote a rewarding work environment.